Diagnosis of cytomegalovirus (CMV) infection in pediatric transplant patients by the antigenemia, shell vial, and conventional culture assays performed on blood: correlation with CMV disease.
BACKGROUND
Human cytomegalovirus (CMV) is a significant cause of morbidity and mortality in transplant recipients. Isolation of CMV from blood leukocytes (CMV viremia) is considered predictive of CMV disease in transplant recipients. Therefore, investigation of methods for the rapid detection of CMV in the blood is important for diagnosis and management of these patients.


OBJECTIVE
To compare three techniques for the diagnosis and monitoring of CMV infection in a pediatric transplant population through the quantitative detection of CMV in peripheral blood leukocytes (PBL).


METHODS
Serial blood specimens were obtained for most patients. After separation of the PBL from each specimen, aliquots of the PBL were used for direct detection of CMV antigenemia by immunoperoxidase staining of acetone-fixed cells (CMV-vue kit, INCSTAR), and by immunofluorescence staining of formaldehyde-fixed cells (Complete 1C3 kit, Biosoft Argene). PBL were also inoculated into conventional cell culture tubes and shell vials. Patients' medical records were reviewed to ascertain the clinical significance of the results.


RESULTS
A total of 154 specimens obtained from 38 pediatric transplant recipients were evaluated. CMV was detected in 16 specimens obtained from eight patients: 11 specimens were found positive with the CMV-vue kit, 10 with the Complete 1C3 kit, four by conventional culture, and one by the shell vial assay. Seven of the eight patients with CMV-positive PBL had clinical signs and other laboratory evidence of active CMV infection. In general, a high-level antigenemia was demonstrated in the presence of clinical disease, but there were exceptions.


CONCLUSIONS
The two antigenemia kits were more sensitive than conventional culture and the shell vial assay for the detection of CMV in the blood of pediatric transplant patients. Our results suggest that CMV antigenemia is a sensitive and specific rapid method for the diagnosis and monitoring of CMV infection in our patient population.
Pedneault
L
L
Department of Microbiology and Immunology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada.
Anglow
M
M
Alfieri
C
C
Rubin
E
E